Failure to control an outbreak of multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: Emergence and ongoing transmission of a fluoroquinolone-resistant strain

Infection Control and Hospital Epidemiology

Volumn 26, Issue 3, 2005, Pages 248-255

  Carter, Rosalind J ^a,g   Sorenson, Genevieve ^c   Heffernan, Richard ^a   Kiehlbauch, Julia A ^d   Kornblum, John S ^b   Leggiadro, Robert J ^e   Nixon, Lucia J ^c   Wertheim, William A ^f   Whitney, Cynthia G ^h   Layton, Marcelle ^a,b  

^a New York City Department of Health   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c St Elizabeth Ann's Hlth Care/R C   (United States)

^d WADSWORTH CENTER   (United States)

^e ST VINCENT S HOSPITAL   (United States)

^f STONY BROOK UNIVERSITY   (United States)

^g CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^h NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

OFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; VANCOMYCIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; EPIDEMIC; FEMALE; HEALTH CARE FACILITY; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIDRUG RESISTANCE; RISK FACTOR; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIBIOTIC PROPHYLAXIS; BACTERIAL VACCINES; CROSS INFECTION; DISEASE OUTBREAKS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, MULTIPLE; ELECTROPHORESIS, GEL, PULSED-FIELD; FEMALE; HEALTH FACILITIES; HUMANS; LENGTH OF STAY; LONG-TERM CARE; MALE; MIDDLE AGED; NASOPHARYNGEAL DISEASES; NEW YORK; PNEUMOCOCCAL INFECTIONS; RISK FACTORS; STREPTOCOCCUS PNEUMONIAE;

EID: 20144389081     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502534     Document Type: Article

References (36)

1. Whitney CG, Farley MM, Hadler J, et al. Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med 2000;343:1917-1924.
2. Mandell LA, Bartlett JG, Dowell SF, et al. Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. Clin Infect Dis 2003;37:1405-1433.
3. Pletz MW, McGee L, Jorgensen JH, et al. Levofloxacin-resistant invasive Streptococcus pneumoniae in the US: evidence for clonal spread and the impact of the conjugate pneumococcal vaccine. Antimicrob Agents Chemother. 2004;48:3491-3497.
4. Doern GV, Brueggemann AB, Huynh H, Wingert E. Antimicrobial resistance to Streptococcus pneumoniae in the United States, 1997-98. Emerg Infect Dis 1999;5:757-765.
5. Chen DK, McGeer A, de Azavedo JC, Low DE. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med 1999;341:233-239.
6. Jones RN, Pfaller MA, Doern GV. Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season. Diagn Microbiol Infect Dis 1998;32:119-126.
7. Sheppard DC, Bartlett KA, Lampiris HW. Streptococcus pneumoniae transmission in chronic-care facilities: description of an outbreak and review of management strategies. Infect Control Hosp Epidemiol 1998; 19:851-853.
8. Kupronis BA, Richards CL, Whitney CG. The Active Bacterial Core Surveillance Team: invasive pneumococcal disease in older adults residing in long-term care facilities and in the community. J Am Geriatr Soc 2003;51:1520-1525.
9. Nuorti JP, Butler, JC, Crutcher JM, et al. An outbreak of multidrug-resistant pneumococcal pneumonia and bacteremia among unvaccinated nursing home residents. N Engl J Med 1998;338:1861-1868.
10. Outbreaks of pneumococcal pneumonia among unvaccinated residents in chronic-care facilities: Massachusetts, October 1995, Oklahoma, February 1996, and Maryland, May-June 1996. MMWR 1997;46:60-62.
11. Gleich S, Morad Y, Echague R, et al. Streptococcus pneumoniae serotype 4 outbreak in a home for the aged: report and review of recent outbreaks. Infect Control Hosp Epidemiol 2000;21:711-717.
12. Facklam RR, Washington JA Streptococcus and related catalase-negative gram-positive cocci. In: Balows A, Hausler WJ, Herrmann KL, Isenberg HD, Shadomy HJ, eds. Manual of Clinical Microbiology, ed. 5. Washington, DC: American Society for Microbiology; 1991:238-257.
13. Austrian R. The quellung reaction, a neglected microbiologic technique. Mt Sinai J Med 1976;43:699-705.
14. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests, ed. 5. Villanova, PA: National Committee for Clinical Laboratory Standards; 1997. Approved standard M7-A4.
15. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing. Villanova, PA: National Committee for Clinical Laboratory Standards; 1995.
16. Jorgensen JH, Ferraro MJ, McElmeel ML, Spargo J, Swenson JM, Tenover FC. Detection of penicillin and extended-spectrum cephalosporin resistance among Streptococcus pneumoniae clinical isolates by use of the E-test. J Clin Microbiol 1994;32:159-163.
17. Smith CL, Cantor CR. Purification, specific fragmentation, and separation of large DNA molecules. Methods Enzymol 1987;155:449-467.
18. Tenover FC, Arbeit RD, Goering RV, et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233-2239.
19. Fry AM, Udeagu CCN, Soriano-Gabarro M, et al. Persistence of fluoroquinolone-resistant, multidrug-resistant Streptococcus pneumoniae in a long-term-care facility: efforts to reduce intrafacility transmission. Infect Control Hosp Epidemiol 2005;26:239-247.
20. Hoge CW, Reichler MR, Dominguez, EA, et al. An epidemic of pneumococcal disease in an overcrowded, inadequately ventilated jail. N Engl J Med 1994;331:643-648.
21. Unsworth DJ, Rowen D, Carne C, Sonnex C, Baglin T, Brown DL. Defective IgG2 response to Pneumovax in HIV seropositive patients. Genitourin Med 1993;69:373-376.
22. Reichler MR, Allphin AA, Breiman RF, et al. The spread of multiply resistant Streptococcus pneumoniae at a day care center in Ohio. J Infect Dis 1992;166:1346-1353.
23. Rauch AM, O'Ryan M, Van R, Pickering LK. Invasive disease due to multiply resistant Streptococcus pneumoniae in a Houston, Texas, daycare center. Am J Dis Child 1990;144:923-927.
24. Cherian T, Steinhoff MC, Harrison LH, Rohn D, McDougal LK, Dick J. A cluster of invasive pneumococcal disease in young children in child care, JAMA 1994;271:695-697.
25. Craig AS, Erwin P, Schaffner W, et al. Carnage of multidrug-resistant Streptococcus pneumoniae and impact of chemoprophylaxis during an outbreak of meningitis at a day care center. Clin Infect Dis 1999;29: 1257-1264.
26. De Galan BE, van Tilburg PM, Sluijter M, et al. Hospital-related outbreak of infection with multidrug-resistant Streptococcus pneumoniae in the Netherlands. J Hosp Infect 1999;42:185492.
27. Hooper DC. Mechanisms of action of antimicrobials: focus on fluoroquinolones. Clin Infect Dis 2001;32(suppl 1):S9-S15.
28. Davidson R, Cavalcanti R, Brunton JL, et al. Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia. N Engl J Med 2002;346:747-750.
29. Ho PL, Tse WS, Tsang KW, et al. Risk factors of acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin Infect Dis 2001;32:701-707.
30. Weiss K, Restieri C, Gauthier R, et al. A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae. Clin Infect Dis 2001; 33:517-522.
31. Broome CV, Facklam RR, Fraser DW. Pneumococcal disease after pneumococcal vaccination: an alternative method to estimate the efficacy of pneumococcal vaccine. N Engl J Med 1980;303:549-552.
32. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991; 325:1453-1460.
33. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993;270:1826-1831.
34. Dworkin MS, Ward JW, Hanson DL, Jones JL, Kaplan JE. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin Infect Dis 2001;32:794-800.
35. Breiman RF, Keller DW, Phelan MA, et al. Evaluation of the 23-valent pneumococcal capsular polysaccharide vaccine for HIV-infected patients. Arch Intern Med 2000;160:2633-2638.
36. Guidelines for preventing opportunistic infections among HIV-infected persons: 2002 recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR 2002;51(RR-8):11-12.